Status:
COMPLETED
Dose-response Relationship of Phototherapy for Hyperbilirubinaemia Using Diodes: is There a "Saturation Point"
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Neonatal Hyperbilirubinemia
Eligibility:
All Genders
33+ years
Phase:
NA
Brief Summary
Background: Using light emitting diodes (LED's) during conventional phototherapy it is possible to reduce the distance from light source to infant, thereby increasing light irradiance. Objective: To ...
Eligibility Criteria
Inclusion
- Gestational age ≥ 33 weeks
- Uncomplicated neonatal hyperbilirubinemia
Exclusion
- \< 33 weeks
- infants in incubators
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT01470820
Start Date
July 1 2009
End Date
December 1 2010
Last Update
November 11 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Department, Aalborg Sygehus, Aarhus University Hospital
Aalborg, Denmark, 9000